WMSA
IBB icon

Weiss Multi-Strategy Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,000
Closed -$522K – 452
2016
Q1 		$522K Buy
+6,000
New +$537K 0.02% 382

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
SG
Societe Generale $14.1B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IBB Position: Q2 2016 in Review

Weiss Multi-Strategy Advisers sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 6,000 shares — an estimated $522K sold.

Weiss Multi-Strategy Advisers first reported a position in IBB in Q1 2016 and held it in 1 quarter. The position peaked at $522K in Q1 2016. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

  • Weiss Multi-Strategy Advisers reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 6,000 iShares Biotechnology ETF shares in Q2 2016, an estimated $522K.
  • Weiss Multi-Strategy Advisers first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's iShares Biotechnology ETF position peaked at $522K in Q1 2016.
  • 428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.